Astrazeneca

Saphnelo

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Astrazeneca

Saphnelo HCPCS:

J0491

HCPCS Code Descriptor:

Injection, anifrolumab-fnia, 1 mg

Category:

J Code

Saphnelo NDCs:

00310-3040-00

Primary Type:

Immunology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Saphnelo CPT Codes:

Potential CPT administration codes for Saphnelo can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Saphnelo:

Saphnelo is an Immunology drug manufactured by Astrazeneca and administered via the Intravenous route of administration. The J Code: J0491 is aligned to the drug Saphnelo.

ACCESS PRICING AND MORE BY REGISTERING

J0491 Added Date:

April 1, 2022

J0491 Effective Date:

April 1, 2022

J0491 Termination Date:

HCPCS Active

Saphnelo billing and coding information can be found through Astrazeneca at the link below:
Saphnelo patient assistance information can be found through The AZ&Me Prescription Savings Program at the URL: https://www.azandmeapp.com/prescriptionsavings/
Saphnelo prescribing information can be found at the link below:
Information regarding Saphnelo’s side effects can be found at MedlinePlus